Ellen 't Hoen - @ellenthoen.bsky.social

I have moved to BlueSky. If you do too, you can follow me there: @ellenthoen.bsky.social

[Ellen 't Hoen - @ellenthoen.bsky.social @ellenthoen]

I am one of them. Mass X-odus: professionals desert Elon Musk’s network https://t.co/DcwR0QgZVm #XIT

[Ellen 't Hoen - @ellenthoen.bsky.social @ellenthoen]

Ik heb net de petitie ter ondersteuning van het Nederlandse #Geneesmiddelenbulletin getekend. Doe het ook: https://t.co/hBKrjRKShd

[Maria Van Kerkhove @mvankerkhove]

🆕 @WHO Disease Outbreqk News #Marburg virus disease– The Republic of Rwanda https://t.co/7B8wMitAwS

[Health Action International @HAImedicines]

In a new guest blog by @Kieranpharkin, @susanmsmith & @LarkinJames, we learn how members of the Irish College of General Practitioners made the momentous decision to stop accepting funding from the pharma industry. 📖Read the blog to find out more: https://t.co/lwJLtGyluj

[Ellen 't Hoen - @ellenthoen.bsky.social @ellenthoen]

Pharma is still struggling to widen access to medicines and reach patients, in LMICs. With some pointed quotes from @AtMIndex director @JayasreeKIyer about the "big gap between what the companies say and what they do".
https://t.co/kuPj05LoZn via @statnews

[Ellen 't Hoen - @ellenthoen.bsky.social @ellenthoen]

Finally. https://t.co/ggt7DgAVt8

[Winnie Byanyima @Winnie_Byanyima]

An HIV prevention drug that is 100% effective: this is a game-changer! Now to ensure lives over profit.
Pleased to see @TheLancet back @UNAIDS' call for @GileadSciences to make lenacapavir available rapidly & affordably to all who need in low- & middle-income countries.
https://t.co/l4m7tpuak9

[Spotlight @SpotlightNSP]

We scored a big win when J&J dropped their patent on #TB medicine after the @CompComSA initiated a probe. 20 years ago, a similar case helped drive down #antiretroviral prices, write @_HassanF and Leena Menghaney. @HealthJusticeIn @MSF @HealthJusticeIn

https://t.co/IORBMmJS4n

[Maria Van Kerkhove @mvankerkhove]

. @WHO urges rapid access to #mpox diagnostic tests, invites manufacturers to emergency review https://t.co/G1xZhY5eSV

[Balasubramaniam @ThiruGeneva]

Monday, September 2nd, 2024 at 2 PM CEST: Reflections on the IP/Technology transfer provisions of the @WHO Pandemic Agreement featuring @jamie_love
@ellenthoen and Luis Villarroel #INB11 h/t @SchoutenArianna

[Spotlight @SpotlightNSP]

Our big story this week: A potentially landmark court case on a cystic fibrosis treatment has been dropped following a price cut. The court was being asked to grant a compulsory license https://t.co/A9kEJqlxVw @tac @jamie_love @MSFAccess @ellenthoen @SECTION27news @ThiruGeneva

[Ellen 't Hoen - @ellenthoen.bsky.social @ellenthoen]

Amsterdam UMC: Ronald Plasterk claimde ten onrechte alleenrecht patenten - https://t.co/44xSuD4KnC https://t.co/44xSuD4KnC

[Ellen 't Hoen - @ellenthoen.bsky.social @ellenthoen]

Reviewing TRIPS, an opportunity for evidence-based policies, writes KM Gopakumar of @3rdworldnetwork (and overdue) https://t.co/ixxS85iRR4

[Helen Clark @HelenClarkNZ]

On current settings, people most at risk in low-income countries won’t get fast access to vaccines against #Mpox. The inequitable system experienced during #Covid_19 #pandemic has not changed. No #pandemic agreement covering these issues has been negotiated. WTO won’t move either

[Ellen 't Hoen - @ellenthoen.bsky.social @ellenthoen]

@sakirkhader Ik heb met veel respect naar u gekeken en geluisterd. Dank!

[Ellen 't Hoen - @ellenthoen.bsky.social @ellenthoen]

Pharma funded patient group removes critical comments upon funder’s demand. https://t.co/79aRYcHloS

[Reuters Health @Reuters_Health]

Pfizer's , GSK's and Moderna's competition for arms for their new respiratory syncytial virus (RSV) vaccines is on Wall Street's watch list for when the companies report earnings later this week. https://t.co/kl0pEw08Ob https://t.co/kl0pEw08Ob

[Balasubramaniam @ThiruGeneva]

Drugmaker Sinergium to share bird flu vaccine data globally, says WHO
https://t.co/mFXUlv7JRy

[Ellen 't Hoen - @ellenthoen.bsky.social @ellenthoen]

Good @TheLancet piece on the Pharmaceutical Accountability Foundation’s @StichtingFTV legal case against @abbvie for its excessive pricing of Humira https://t.co/URl2EKolDy

[Ellen 't Hoen - @ellenthoen.bsky.social @ellenthoen]

A pricey Gilead HIV drug could be made for dramatically less than the company charges, researchers say https://t.co/MdOWC0n5Zy via @statnews